The House Ways and Means Committee on Wednesday will mark up four bills intended to address the opioid crisis. According to committee leaders, the bills will include provisions from nearly two dozen separate proposals, including two AHA-supported bills that cleared the Energy and Commerce Committee last week: H.R. 4841, which would standardize electronic prior authorization for prescription drugs under Medicare Part D; and H.R. 5686, which would require Medicare prescription drug plans to provide certain enrollees with information on the adverse effects of opioid overuse and coverage of alternative pain medications and devices. On Thursday, the Energy and Commerce Committee will mark up several bills, including AHA-supported bills that would improve information sharing regarding patients’ substance use disorder treatment history, and amend the Medicaid Institutions for Mental Disease exclusion. The Senate Health, Education, Labor and Pensions Committee last month approved bipartisan legislation that includes measures to reauthorize funding to states to address opioid abuse and provide support to improve the interoperability of state prescription drug monitoring programs, and the Senate Finance Committee is also considering opioid-related legislation.

Related News Articles

Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
The House Energy and Commerce Subcommittee on Health Sept. 10 advanced the Title VIII Nursing Workforce Reauthorization Act (H.R. 3593), AHA-supported…
Headline
The House Appropriations Committee Sept. 9 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services, Education…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The AHA Sept. 4 expressed support for the Hospitals As Naloxone Distribution Sites Act (H.R. 5120), legislation that would require Medicare and Medicaid to…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…